secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001193125-25-182692
Event type: debt
Sentiment:  neutral
Materiality: 0.90
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Evolent Health Announces $140M Convertible Note Offering and Discloses DOJ Investigation
--------------------------------------------------------------------------------

- Evolent Health intends to offer $140.0M aggregate principal amount of convertible senior notes due 2031, with an option for an additional $20.0M.
- The company plans to use up to $100M of net proceeds to repurchase a portion of its 1.50% convertible senior notes due 2025 and about $40M to repurchase shares of its Class A common stock.
- Evolent disclosed it received a Civil Investigative Demand from the DOJ on August 12, 2025, regarding a False Claims Act investigation involving former customer's diagnosis codes since 2016.
- The notes will be convertible into cash, stock, or a combination, subject to conversion rights termination conditions after August 20, 2026.
- The offering is private under Rule 144A, and the securities are not registered under the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000119312525182692/0001193125-25-182692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000119312525182692/d24921d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-182692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer